BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17428316)

  • 1. Ovarian dysfunction and FMR1 alleles in a large Italian family with POF and FRAXA disorders: case report.
    Miano MG; Laperuta C; Chiurazzi P; D'Urso M; Ursini MV
    BMC Med Genet; 2007 Apr; 8():18. PubMed ID: 17428316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation.
    Bodega B; Bione S; Dalprà L; Toniolo D; Ornaghi F; Vegetti W; Ginelli E; Marozzi A
    Hum Reprod; 2006 Apr; 21(4):952-7. PubMed ID: 16361284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premature ovarian failure and fragile X female premutation carriers: no evidence for a skewed X-chromosome inactivation pattern.
    Rodriguez-Revenga L; Madrigal I; Badenas C; Xunclà M; Jiménez L; Milà M
    Menopause; 2009; 16(5):944-9. PubMed ID: 19373114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome.
    Tejada MI; García-Alegría E; Bilbao A; Martínez-Bouzas C; Beristain E; Poch M; Ramos-Arroyo MA; López B; Fernandez Carvajal I; Ribate MP; Ramos F
    Menopause; 2008; 15(5):945-9. PubMed ID: 18427356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study.
    Rohr J; Allen EG; Charen K; Giles J; He W; Dominguez C; Sherman SL
    Hum Reprod; 2008 May; 23(5):1220-5. PubMed ID: 18310677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premature ovarian failure (POF) and fragile X premutation females: from POF to to fragile X carrier identification, from fragile X carrier diagnosis to POF association data.
    Uzielli ML; Guarducci S; Lapi E; Cecconi A; Ricci U; Ricotti G; Biondi C; Scarselli B; Vieri F; Scarnato P; Gori F; Sereni A
    Am J Med Genet; 1999 May; 84(3):300-3. PubMed ID: 10331612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction.
    Syrrou M; Georgiou I; Patsalis PC; Bouba I; Adonakis G; Pagoulatos GN
    Am J Med Genet; 1999 May; 84(3):306-8. PubMed ID: 10331614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency.
    De Caro JJ; Dominguez C; Sherman SL
    Ann N Y Acad Sci; 2008; 1135():99-111. PubMed ID: 18574214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abnormal function of ovaries in women carriers of premutation in the FMR1 gene].
    Lisik MZ
    Wiad Lek; 2007; 60(5-6):265-9. PubMed ID: 17966892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FRAXA premutation associated with premature ovarian failure.
    Vianna-Morgante AM; Costa SS; Pares AS; Verreschi IT
    Am J Med Genet; 1996 Aug; 64(2):373-5. PubMed ID: 8844084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency.
    Streuli I; Fraisse T; Ibecheole V; Moix I; Morris MA; de Ziegler D
    Fertil Steril; 2009 Aug; 92(2):464-70. PubMed ID: 18973899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very early premature ovarian failure in two sisters compound heterozygous for the FMR1 premutation.
    Van Esch H; Buekenhout L; Race V; Matthijs G
    Eur J Med Genet; 2009; 52(1):37-40. PubMed ID: 19041959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature ovarian failure in the fragile X syndrome.
    Sherman SL
    Am J Med Genet; 2000; 97(3):189-94. PubMed ID: 11449487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premature ovarian failure: a phenotypic expression of fragile X premutation.
    Holoch K; Stein Q; Flanagan J; Hansen K
    S D Med; 2008 Jan; 61(1):13, 15. PubMed ID: 18323308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of expanded unmethylated alleles for FRAXA/FRAXE loci in the intellectual performance among Brazilian mentally impaired males.
    Barros Santos C; Gonçalves Pimentel MM
    Int J Mol Med; 2003 Sep; 12(3):385-9. PubMed ID: 12883656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies.
    Gleicher N; Weghofer A; Barad DH
    Fertil Steril; 2009 May; 91(5):1707-11. PubMed ID: 18384784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aetiology of premature ovarian failure.
    Vujovic S
    Menopause Int; 2009 Jun; 15(2):72-5. PubMed ID: 19465673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of DNA analysis for diagnostics of hereditary premature ovarian failure].
    Livshyts' HB; Kravchenko SA; Hryshchenko NV; Sudoma IA
    Tsitol Genet; 2005; 39(2):59-63. PubMed ID: 16161415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
    Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
    J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.